Tooth Regeneration Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2024 – 2032
Published on: 2024-08-03 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Tooth Regeneration Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2024 – 2032
Tooth Regeneration Market Size
Tooth Regeneration Market size is anticipated to expand considerably from 2024 to 2032 driven by the awareness about advantages of guided tissue regeneration procedures, such as the ability to preserve natural teeth as well as its less invasive nature as compared to bone grafting surgery.
Furthermore, the capability of dental regeneration to reverse the consequences of periodontal diseases will further aid the industry gains, as the technique encourages the growth of the jawbone.
According to the WHO, nearly 2.3 billion people have dental caries of permanent teeth, while more than 530 million children are infected with primary teeth caries worldwide. Rising prevalence of dental caries and the subsequent rise in the incidence of tooth loss is bolster the demand for stem cell tooth regeneration techniques as a substitute for dental implants. Likewise, the significant progress in stem cell research, alongside the emergence of laser dentistry as an effective method for treating teeth cavities, will favor the market expansion.
Tooth Regeneration Market Trends
The industry is experiencing notable trends due to advancements in regenerative medicine and dental technology. The rise of stem cell-based therapies for tooth regeneration offers promising alternatives to traditional dental implants. Furthermore, 3D printing technology enables the fabrication of customized scaffolds and structures for tooth tissue regeneration, enhancing treatment efficacy and patient outcomes. Additionally, the growing demand for minimally invasive procedures and natural tooth restoration methods is driving R&D in biomaterials and tissue engineering approaches. Overall, these trends signify a shift towards regenerative solutions in dentistry, revolutionizing tooth replacement and restoration techniques.
Tooth Regeneration Market Analysis
Based on type, the tooth enamel segment will account for a major share in the tooth regeneration industry by 2032, credited to the low intake of calcium in countries like the United States, which may lead to tooth decay and eventually result in the breakdown of enamel. As per the National Dental Epidemiology Programme survey of England, the presence of tooth enamel or dentinal decay in 5 year old children was 29.3% in 2022. In addition, the potential development of complications among people with enamel hypoplasia, such as tooth cavities or caries, will further augment the need for tooth enamel regeneration procedures in the upcoming years.
Europe is poised to emerge as a lucrative revenue pocket for tooth regeneration market players by 2032, considering the increased rate of tooth decay among the younger population in Italy and Germany. Additionally, the rising number of elderly people will further impel the adoption of dental regeneration techniques, as older people have the highest rate of periodontal disease and tooth loss.
Tooth Regeneration Market Share
Key players functioning in the industry include
- Zimmer Biomet
- Dentsply Sirona
- 3M
- Straumann
- StemCells
- Cook Medical
- BioMimetic Therapeutics (Wright Medical Group N.V.)
- CryoLife
- Integra LifeSciences
- Ocata Therapeutics (formerly Advanced Cell Technology)
- Unilever
These companies are focusing on new service launches, acquisitions, mergers, and other strategies to boost their business footprint in the global market.
Tooth Regeneration Industry News
- In February 2024, An Osaka pharmaceutical startup, Toregem Biopharma Co., announced that it will begin clinical trials soon on a novel drug aimed at stimulating the growth of new teeth in humans. Backed by Kyoto University, the company has already achieved success in animal models and hopes for a human trial breakthrough by 2030, potentially revolutionizing dental medicine.